MISOPROSTOL

MISOPROSTOL was reported 9778 times

MISOPROSTOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LABOUR AUGMENTATION 8 0.8000
1 UTERINE TACHYSYSTOLE 104 0.7172
2 ABORTION INDUCED INCOMPLETE 23 0.6389
3 POST ABORTION INFECTION 15 0.6250
4 ABORTION INCOMPLETE 1158 0.6216
5 INDUCED ABORTION FAILED 73 0.5573
6 ENDOMETRITIS BACTERIAL 6 0.5455
7 POSTPARTUM STRESS DISORDER 9 0.4500
8 INDUCED ABORTION HAEMORRHAGE 9 0.3750
9 FOETAL EXPOSURE DURING DELIVERY 207 0.3053
10 FOETAL METHOTREXATE SYNDROME 20 0.2778
11 POST ABORTION COMPLICATION 8 0.2581
12 BIRTH TRAUMA 16 0.2462
13 ENDOMETRITIS 157 0.2361
14 TRAUMATIC DELIVERY 12 0.2353
15 PRECIPITATE LABOUR 15 0.2239
16 POST ABORTION HAEMORRHAGE 30 0.2098
17 TRUNCUS ARTERIOSUS PERSISTENT 41 0.2060
18 RETAINED PRODUCTS OF CONCEPTION 40 0.1951
19 VASCULAR RESISTANCE SYSTEMIC INCREASED 10 0.1923
20 ANAPHYLACTOID SYNDROME OF PREGNANCY 16 0.1667
21 FOETAL HEART RATE DECREASED 100 0.1603
22 PERINATAL STROKE 8 0.1569
23 ABNORMAL LABOUR 19 0.1473
24 CERVIX ENLARGEMENT 7 0.1429
25 LABOUR PAIN 11 0.1209
26 UTERINE CERVICAL LACERATION 11 0.1209
27 MICROGENIA 7 0.1186
28 PERINEAL INJURY 18 0.1184
29 UTERINE ATONY 31 0.1183
30 MOEBIUS II SYNDROME 7 0.1111
31 FOETAL HEART RATE DISORDER 21 0.1088
32 AMNIOCENTESIS ABNORMAL 17 0.1083
33 UTERINE HYPERSTIMULATION 11 0.1078
34 UTERINE TENDERNESS 9 0.1047
35 NEONATAL RESPIRATORY ARREST 14 0.0959
36 ABORTION INFECTED 6 0.0923
37 KIDNEY DUPLEX 22 0.0917
38 CONGENITAL MULTIPLEX ARTHROGRYPOSIS 18 0.0882
39 RETAINED PLACENTA OR MEMBRANES 26 0.0858
40 DELAYED FONTANELLE CLOSURE 8 0.0833
41 AMNIOTIC BAND SYNDROME 9 0.0818
42 UTERINE HYPERTONUS 22 0.0812
43 UTERINE RUPTURE 112 0.0792
44 CONGENITAL CYSTIC LUNG 9 0.0750
45 ADACTYLY 12 0.0745
46 INFANTILE HAEMANGIOMA 12 0.0741
47 CONJOINED TWINS 7 0.0707
48 FOETAL HEART RATE INCREASED 6 0.0682
49 CONGENITAL BRAIN DAMAGE 7 0.0680
50 MICROGNATHIA 33 0.0660
51 MECONIUM IN AMNIOTIC FLUID 23 0.0653
52 BLOODY DISCHARGE 73 0.0639
53 CONGENITAL MEGAURETER 12 0.0622
54 CLINODACTYLY 17 0.0618
55 EXTERNAL AUDITORY CANAL ATRESIA 10 0.0617
56 NEONATAL HYPOXIA 51 0.0617
57 VITELLO-INTESTINAL DUCT REMNANT 7 0.0609
58 LOW SET EARS 25 0.0608
59 CONGENITAL TRICUSPID VALVE ATRESIA 9 0.0600
60 BRACHYCEPHALY 6 0.0594
61 CONGENITAL NAIL DISORDER 7 0.0574
62 MENINGOCELE 9 0.0573
63 UTERINE HYPOTONUS 7 0.0556
64 CARDIAC SEPTAL DEFECT 38 0.0529
65 LABOUR INDUCTION 7 0.0515
66 UTERINE CONTRACTIONS ABNORMAL 14 0.0515
67 SKELETAL DYSPLASIA 7 0.0493
68 POSTPARTUM HAEMORRHAGE 66 0.0490
69 WRIST DEFORMITY 30 0.0488
70 COMPLICATION OF DELIVERY 14 0.0484
71 ANOMALY OF EXTERNAL EAR CONGENITAL 15 0.0475
72 HIGH ARCHED PALATE 8 0.0468
73 CONGENITAL CARDIOVASCULAR ANOMALY 39 0.0465
74 HYPERTELORISM OF ORBIT 19 0.0455
75 FOETAL HEART RATE ABNORMAL 41 0.0443
76 HAEMANGIOMA CONGENITAL 21 0.0442
77 LABOUR COMPLICATION 10 0.0427
78 MATERNAL EXPOSURE DURING DELIVERY 42 0.0424
79 POOR WEIGHT GAIN NEONATAL 8 0.0408
80 GENITALIA EXTERNAL AMBIGUOUS 7 0.0405
81 CONGENITAL PULMONARY VALVE ATRESIA 9 0.0404
82 FOETAL DISTRESS SYNDROME 85 0.0400
83 MENINGOMYELOCELE 24 0.0400
84 RUPTURED ECTOPIC PREGNANCY 29 0.0374
85 ANTEPARTUM HAEMORRHAGE 15 0.0361
86 BRACHYDACTYLY 7 0.0355
87 CONGENITAL CORONARY ARTERY MALFORMATION 6 0.0355
88 INTERNATIONAL NORMALISED RATIO FLUCTUATION 73 0.0352
89 ANAEMIA OF PREGNANCY 6 0.0347
90 ARNOLD-CHIARI MALFORMATION 33 0.0346
91 MICROCEPHALY 44 0.0343
92 DOUBLE OUTLET RIGHT VENTRICLE 10 0.0339
93 ARRESTED LABOUR 8 0.0338
94 LIMB REDUCTION DEFECT 19 0.0325
95 NEONATAL ASPHYXIA 23 0.0324
96 ANENCEPHALY 18 0.0319
97 SKULL MALFORMATION 20 0.0311
98 RESPIRATORY DISORDER NEONATAL 50 0.0308
99 APPARENT LIFE THREATENING EVENT 13 0.0306
100 CONGENITAL CHOROID PLEXUS CYST 9 0.0295
101 NEWBORN PERSISTENT PULMONARY HYPERTENSION 8 0.0285
102 CEREBRAL HAEMORRHAGE NEONATAL 6 0.0283
103 VULVOVAGINAL INJURY 16 0.0281
104 CONGENITAL HYDROCEPHALUS 14 0.0276
105 URINARY BLADDER RUPTURE 7 0.0276
106 TOXIC SHOCK SYNDROME 17 0.0270
107 PREMATURE SEPARATION OF PLACENTA 41 0.0266
108 CONGENITAL FOOT MALFORMATION 12 0.0264
109 CONGENITAL EYE DISORDER 7 0.0262
110 FOETAL HEART RATE DECELERATION 6 0.0259
111 FOETAL HEART RATE DECELERATION ABNORMALITY 18 0.0255
112 POLYHYDRAMNIOS 26 0.0255
113 VESICOURETERIC REFLUX 10 0.0247
114 NAIL BED BLEEDING 14 0.0246
115 RENAL APLASIA 17 0.0242
116 PULMONARY HYPOPLASIA 19 0.0241
117 CONGENITAL HYDRONEPHROSIS 17 0.0238
118 CEREBRAL VENTRICLE DILATATION 27 0.0234
119 CYANOSIS NEONATAL 15 0.0234
120 PELVIC INFLAMMATORY DISEASE 34 0.0228
121 LYME DISEASE 75 0.0225
122 PREGNANCY 449 0.0224
123 MICROPHTHALMOS 6 0.0221
124 PELVIC INFECTION 10 0.0216
125 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 23 0.0213
126 GROSS MOTOR DELAY 6 0.0211
127 CONGENITAL DIAPHRAGMATIC HERNIA 8 0.0205
128 BRADYCARDIA FOETAL 17 0.0205
129 CONGENITAL MUSCULOSKELETAL ANOMALY 9 0.0204
130 APGAR SCORE LOW 26 0.0202
131 TACHYCARDIA FOETAL 10 0.0200
132 PLACENTAL INSUFFICIENCY 16 0.0199
133 UTERINE DILATION AND CURETTAGE 18 0.0199
134 LIMB MALFORMATION 15 0.0190
135 NOSE DEFORMITY 7 0.0188
136 EXOMPHALOS 10 0.0186
137 SMALL FOR DATES BABY 92 0.0185
138 FOETAL DEATH 95 0.0183
139 CONGENITAL CYSTIC KIDNEY DISEASE 15 0.0177
140 CONGENITAL HAND MALFORMATION 12 0.0175
141 HEART DISEASE CONGENITAL 62 0.0175
142 HAEMORRHAGE IN PREGNANCY 25 0.0174
143 GESTATIONAL DIABETES 83 0.0174
144 UTERINE HAEMORRHAGE 74 0.0174
145 VENTRICULAR SEPTAL DEFECT 97 0.0169
146 CONGENITAL NOSE MALFORMATION 9 0.0169
147 SYNDACTYLY 14 0.0168
148 CEREBRAL PALSY 16 0.0168
149 AGITATION NEONATAL 16 0.0167
150 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 11 0.0162
151 OESOPHAGEAL ATRESIA 10 0.0160
152 SPINA BIFIDA 33 0.0158
153 CONVULSION NEONATAL 8 0.0152
154 INDUCED LABOUR 9 0.0151
155 STILLBIRTH 73 0.0151
156 CRANIOSYNOSTOSIS 13 0.0150
157 UTERINE CERVIX STENOSIS 8 0.0150
158 ECTOPIC PREGNANCY 44 0.0143
159 TRACHEO-OESOPHAGEAL FISTULA 9 0.0141
160 FOETAL GROWTH RETARDATION 11 0.0140
161 IRON DEFICIENCY 62 0.0138
162 HYPERBILIRUBINAEMIA NEONATAL 8 0.0137
163 HYPOTONIA NEONATAL 21 0.0134
164 MENORRHAGIA 262 0.0133
165 HEART SOUNDS ABNORMAL 10 0.0133
166 NEONATAL DISORDER 21 0.0132
167 UTERINE INFECTION 7 0.0132
168 DYSMORPHISM 31 0.0131
169 HELLP SYNDROME 8 0.0131
170 PYLORIC STENOSIS 11 0.0130
171 ABORTION INDUCED 122 0.0129
172 TALIPES 40 0.0129
173 DENTAL RESTORATION FAILURE 9 0.0125
174 AMNIOTIC CAVITY INFECTION 9 0.0124
175 ABORTION 36 0.0123
176 HAEMORRHAGE 1260 0.0120
177 XEROPHTHALMIA 7 0.0119
178 TEMPERATURE REGULATION DISORDER 26 0.0117
179 PNEUMOCYSTIS JIROVECI PNEUMONIA 26 0.0117
180 LUPUS VULGARIS 14 0.0111
181 VAGINITIS BACTERIAL 7 0.0111
182 ABORTION MISSED 14 0.0110
183 SELECTIVE EATING DISORDER 10 0.0110
184 DEVELOPMENTAL HIP DYSPLASIA 9 0.0108
185 OLIGOHYDRAMNIOS 36 0.0108
186 SMALL INTESTINE ULCER 7 0.0108
187 CLEFT LIP AND PALATE 12 0.0107
188 BODY TINEA 6 0.0107
189 HYPOSPADIAS 22 0.0106
190 UTERINE SPASM 19 0.0104
191 PULMONARY MYCOSIS 8 0.0103
192 HYPOGLYCAEMIA NEONATAL 16 0.0099
193 MULTIPLE CONGENITAL ABNORMALITIES 14 0.0097
194 ATRIAL SEPTAL DEFECT 81 0.0097
195 VAGINAL ODOUR 12 0.0095
196 INTRA-UTERINE DEATH 15 0.0093
197 DEATH NEONATAL 13 0.0093
198 UPPER RESPIRATORY TRACT INFLAMMATION 11 0.0092
199 LARGE FOR DATES BABY 8 0.0091
200 UTERINE ENLARGEMENT 7 0.0088
201 UTERINE PAIN 9 0.0088
202 BRADYCARDIA NEONATAL 11 0.0087
203 ARTERIOSPASM CORONARY 35 0.0087
204 CERVIX DISORDER 6 0.0083
205 MATERNAL EXPOSURE TIMING UNSPECIFIED 31 0.0082
206 IDIOPATHIC THROMBOCYTOPENIC PURPURA 13 0.0082
207 POST PROCEDURAL DISCOMFORT 17 0.0081
208 FOETAL EXPOSURE DURING PREGNANCY 652 0.0080
209 MATERNAL DRUGS AFFECTING FOETUS 61 0.0079
210 PREMATURE RUPTURE OF MEMBRANES 18 0.0075
211 NEONATAL RESPIRATORY DISTRESS 7 0.0074
212 PLACENTAL DISORDER 7 0.0074
213 FOETAL GROWTH RESTRICTION 45 0.0074
214 LICHEN PLANUS 17 0.0073
215 UTERINE PERFORATION 62 0.0073
216 MUSCLE CRAMP 13 0.0073
217 LOW BIRTH WEIGHT BABY 57 0.0072
218 CRYPTORCHISM 8 0.0071
219 PRINZMETAL ANGINA 7 0.0070
220 POLYDACTYLY 8 0.0069
221 STREPTOCOCCAL SEPSIS 8 0.0067
222 PRE-ECLAMPSIA 31 0.0065
223 RED BLOOD CELL SEDIMENTATION RATE INCREASED 72 0.0065
224 UTERINE DISORDER 15 0.0064
225 PATENT DUCTUS ARTERIOSUS 24 0.0060
226 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
227 BONE MARROW OEDEMA 6 0.0058
228 EXPOSURE DURING PREGNANCY 337 0.0054
229 CAESAREAN SECTION 61 0.0052
230 COMPLICATION OF DEVICE INSERTION 104 0.0052
231 DRUG EXPOSURE DURING PREGNANCY 177 0.0052
232 CLEFT PALATE 10 0.0052
233 PNEUMONIA CYTOMEGALOVIRAL 10 0.0051
234 SUSPECTED OFF LABEL USE 23 0.0051
235 PLEURITIC PAIN 14 0.0051
236 PERITONEAL HAEMORRHAGE 7 0.0050
237 LIMB DEFORMITY 8 0.0050
238 JOINT INSTABILITY 7 0.0050
239 BREECH PRESENTATION 6 0.0048
240 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0048
241 HAEMANGIOMA 11 0.0048
242 MATERNAL EXPOSURE DURING PREGNANCY 420 0.0047
243 HYPERTHERMIA MALIGNANT 7 0.0047
244 PELVIC PAIN 84 0.0046
245 INTELLECTUAL DISABILITY 7 0.0046
246 LYMPHOCYTE PERCENTAGE DECREASED 6 0.0045
247 PLATELET COUNT INCREASED 58 0.0044
248 PREMATURE BABY 131 0.0043
249 SECRETION DISCHARGE 54 0.0043
250 MEDICAL DEVICE DISCOMFORT 13 0.0043
251 EMBEDDED DEVICE 42 0.0042
252 SPEECH DISORDER DEVELOPMENTAL 12 0.0042
253 SPINAL DEFORMITY 7 0.0042
254 THROMBOCYTOSIS 15 0.0041
255 VAGINAL HAEMORRHAGE 177 0.0041
256 PREMATURE LABOUR 23 0.0041
257 BLOOD ALBUMIN DECREASED 32 0.0040
258 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 218 0.0040
259 BLOOD PRESSURE DIASTOLIC ABNORMAL 10 0.0039
260 DEVELOPMENTAL DELAY 35 0.0039
261 NORMAL NEWBORN 21 0.0039
262 CLOSTRIDIAL INFECTION 13 0.0038
263 MEDICAL DEVICE PAIN 8 0.0037
264 GROWTH RETARDATION 11 0.0037
265 HYSTERECTOMY 32 0.0037
266 TONGUE OEDEMA 14 0.0037
267 METRORRHAGIA 62 0.0036
268 PROCEDURAL HAEMORRHAGE 14 0.0036
269 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
270 HYPERPYREXIA 15 0.0035
271 ACUTE PULMONARY OEDEMA 19 0.0034
272 HEPATITIS FULMINANT 10 0.0034
273 DEVICE PLACEMENT ISSUE 12 0.0033
274 HAEMORRHAGIC ANAEMIA 14 0.0032
275 DISSEMINATED TUBERCULOSIS 8 0.0031
276 GASTRIC POLYPS 7 0.0031
277 BLOOD LOSS ANAEMIA 7 0.0031
278 AUTISM SPECTRUM DISORDER 17 0.0031
279 PROCEDURAL PAIN 85 0.0031
280 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 8 0.0031
281 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 8 0.0030
282 MUSCLE CONTRACTURE 6 0.0030
283 INTRA-ABDOMINAL HAEMORRHAGE 7 0.0029
284 HAEMODYNAMIC INSTABILITY 22 0.0029
285 PYELONEPHRITIS 25 0.0029
286 VOMITING PROJECTILE 8 0.0028
287 STRABISMUS 8 0.0027
288 STAPHYLOCOCCAL INFECTION 89 0.0027
289 ANAEMIA 510 0.0027
290 FEAR OF DEATH 6 0.0027
291 CIRCULATORY COLLAPSE 45 0.0026
292 ANAL FISSURE 14 0.0026
293 NEPHROGENIC ANAEMIA 12 0.0026
294 RALES 15 0.0026
295 GASTRIC ULCER HAEMORRHAGE 14 0.0025
296 GENITAL HAEMORRHAGE 32 0.0025
297 NYSTAGMUS 13 0.0024
298 DUODENAL ULCER PERFORATION 18 0.0024
299 PEPTIC ULCER 8 0.0024
300 GASTROINTESTINAL NECROSIS 7 0.0024
301 BLOOD LACTATE DEHYDROGENASE INCREASED 38 0.0024
302 SYNOVITIS 43 0.0024
303 PREGNANCY WITH CONTRACEPTIVE DEVICE 21 0.0023
304 SPINAL COLUMN STENOSIS 11 0.0023
305 SPINAL OSTEOARTHRITIS 20 0.0023
306 VAGINAL DISCHARGE 23 0.0023
307 ABDOMINAL TENDERNESS 11 0.0022
308 SHOCK HAEMORRHAGIC 18 0.0022
309 HYPOTONIA 22 0.0022
310 SPONDYLITIS 8 0.0022
311 CONGENITAL ANOMALY 17 0.0022
312 VENTRICULAR HYPOKINESIA 7 0.0022
313 DYSPAREUNIA 10 0.0022
314 ABDOMINAL PAIN LOWER 55 0.0022
315 PAIN IN JAW 61 0.0022
316 LIVE BIRTH 18 0.0021
317 VAGINAL INFECTION 10 0.0021
318 PULMONARY TUBERCULOSIS 9 0.0021
319 HYPERTHERMIA 16 0.0021
320 ACUTE CORONARY SYNDROME 17 0.0021
321 MATERNAL EXPOSURE BEFORE PREGNANCY 14 0.0020
322 BRONCHOPNEUMONIA 7 0.0020
323 JOINT EFFUSION 14 0.0020
324 OVARIAN CYST 20 0.0020
325 TRIGEMINAL NEURALGIA 8 0.0020
326 NECROTISING FASCIITIS 7 0.0020
327 GASTROINTESTINAL PERFORATION 8 0.0019
328 MUSCLE SPASMS 352 0.0019
329 ATELECTASIS 18 0.0019
330 FINGER DEFORMITY 9 0.0019
331 EXPOSURE DURING BREAST FEEDING 6 0.0018
332 INTERSTITIAL LUNG DISEASE 87 0.0018
333 NECROSIS 10 0.0018
334 SKIN ODOUR ABNORMAL 7 0.0018
335 BK VIRUS INFECTION 6 0.0018
336 SYNCOPE 178 0.0018
337 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
338 HELICOBACTER INFECTION 18 0.0017
339 TRISMUS 9 0.0017
340 LARGE INTESTINE PERFORATION 12 0.0017
341 URINE OUTPUT DECREASED 15 0.0017
342 FOOT DEFORMITY 19 0.0017
343 GRIP STRENGTH DECREASED 15 0.0017
344 PREMATURE DELIVERY 27 0.0017
345 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
346 PLEURISY 10 0.0017
347 ABORTION SPONTANEOUS 66 0.0016
348 TOXIC EPIDERMAL NECROLYSIS 25 0.0016
349 MASS 23 0.0016
350 CHOLECYSTITIS CHRONIC 11 0.0016
351 POST-TRAUMATIC STRESS DISORDER 11 0.0016
352 BLOOD UREA INCREASED 27 0.0016
353 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
354 PROTEIN URINE PRESENT 8 0.0016
355 PARAESTHESIA ORAL 23 0.0016
356 IRRITABLE BOWEL SYNDROME 34 0.0016
357 PATHOLOGICAL FRACTURE 8 0.0016
358 DUODENAL ULCER 11 0.0016
359 IMPAIRED WORK ABILITY 33 0.0015
360 C-REACTIVE PROTEIN INCREASED 56 0.0015
361 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
362 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
363 HEPATIC FUNCTION ABNORMAL 57 0.0015
364 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
365 DYSMENORRHOEA 20 0.0015
366 EXPOSURE VIA BREAST MILK 6 0.0015
367 UTERINE LEIOMYOMA 11 0.0015
368 ABDOMINAL PAIN 350 0.0015
369 TIBIA FRACTURE 7 0.0015
370 ULCER HAEMORRHAGE 10 0.0015
371 ANOREXIA 19 0.0015
372 HYDROCEPHALUS 8 0.0015
373 CARDIOMEGALY 18 0.0015
374 ARTHRITIS BACTERIAL 6 0.0015
375 HYPOVOLAEMIC SHOCK 7 0.0015
376 INTERMENSTRUAL BLEEDING 8 0.0014
377 SCREAMING 9 0.0014
378 PELVIC FRACTURE 11 0.0014
379 ABSCESS LIMB 6 0.0014
380 CHILLS 163 0.0014
381 ENTEROCOLITIS 8 0.0014
382 HYPOVOLAEMIA 8 0.0014
383 HAEMATOCRIT DECREASED 27 0.0014
384 CYTOMEGALOVIRUS INFECTION REACTIVATION 6 0.0014
385 DEVICE DEPLOYMENT ISSUE 17 0.0013
386 DRUG INTOLERANCE 128 0.0013
387 CONTRAINDICATED PRODUCT ADMINISTERED 40 0.0013
388 EXOSTOSIS 12 0.0013
389 MOVEMENT DISORDER 42 0.0013
390 PNEUMONIA BACTERIAL 12 0.0013
391 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
392 ANAL ABSCESS 7 0.0013
393 ANAPHYLACTIC SHOCK 33 0.0013
394 PRODUCT USE IN UNAPPROVED INDICATION 317 0.0013
395 STREPTOCOCCAL INFECTION 7 0.0013
396 PERICARDITIS 21 0.0012
397 LUNG INFILTRATION 11 0.0012
398 DEVICE DISLOCATION 54 0.0012
399 ANAPHYLACTIC REACTION 68 0.0012
400 NODULE 16 0.0012
401 ASPHYXIA 10 0.0012
402 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
403 SKIN ATROPHY 7 0.0012
404 CARPAL TUNNEL SYNDROME 17 0.0012
405 SPINAL COMPRESSION FRACTURE 10 0.0012
406 HYPERVENTILATION 7 0.0012
407 RHEUMATOID ARTHRITIS 137 0.0012
408 POST PROCEDURAL HAEMORRHAGE 14 0.0012
409 INFECTION 173 0.0012
410 BREAST TENDERNESS 9 0.0012
411 PYREXIA 409 0.0012
412 TACHYCARDIA 105 0.0012
413 PROCEDURAL COMPLICATION 9 0.0012
414 PERITONITIS 24 0.0012
415 GASTRIC ULCER 22 0.0012
416 MULTI-ORGAN FAILURE 20 0.0012
417 ENCEPHALITIS 8 0.0012
418 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
419 SEPTIC SHOCK 50 0.0011
420 MALABSORPTION 6 0.0011
421 DRUG WITHDRAWAL SYNDROME NEONATAL 17 0.0011
422 CYANOSIS 18 0.0011
423 PLEURAL EFFUSION 69 0.0011
424 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
425 SHOCK 26 0.0011
426 PEMPHIGUS 14 0.0011
427 COMPLICATION OF DEVICE REMOVAL 20 0.0011
428 TENDONITIS 17 0.0011
429 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 78 0.0011
430 BLOOD CHOLESTEROL INCREASED 51 0.0011
431 ORAL DISORDER 8 0.0011
432 HYPERLIPIDAEMIA 13 0.0011
433 HEPATITIS ACUTE 7 0.0011
434 ASPARTATE AMINOTRANSFERASE INCREASED 57 0.0011
435 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
436 HEPATIC ENCEPHALOPATHY 10 0.0011
437 TENDON PAIN 8 0.0011
438 OFF LABEL USE 924 0.0011
439 TENDON RUPTURE 13 0.0011
440 PALLOR 28 0.0010
441 PULMONARY HAEMORRHAGE 8 0.0010
442 ECCHYMOSIS 7 0.0010
443 HEPATOMEGALY 10 0.0010
444 ACUTE MYOCARDIAL INFARCTION 30 0.0010
445 DRUG RESISTANCE 26 0.0010
446 MYOSITIS 9 0.0010
447 HYPOAESTHESIA 150 0.0010
448 OXYGEN SATURATION DECREASED 56 0.0010
449 CARDIAC ARREST 82 0.0010
450 RED BLOOD CELL COUNT DECREASED 28 0.0010
451 METABOLIC ACIDOSIS 31 0.0010
452 INJURY 68 0.0010
453 OSTEOARTHRITIS 41 0.0010
454 NIGHT SWEATS 31 0.0010
455 TENDERNESS 10 0.0010
456 HAEMOGLOBIN DECREASED 98 0.0010
457 GASTRITIS 25 0.0009
458 ULCER 15 0.0009
459 OSTEOMYELITIS 17 0.0009
460 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
461 ACUTE RESPIRATORY FAILURE 18 0.0009
462 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
463 BLOOD IRON DECREASED 11 0.0009
464 GASTROOESOPHAGEAL REFLUX DISEASE 74 0.0009
465 BACTERIAL INFECTION 17 0.0009
466 RENAL FAILURE CHRONIC 7 0.0009
467 VOMITING 427 0.0009
468 PRODUCT COMPLAINT 23 0.0009
469 ADRENAL INSUFFICIENCY 11 0.0009
470 CARDIOVASCULAR DISORDER 23 0.0009
471 BRAIN INJURY 9 0.0009
472 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
473 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
474 POST PROCEDURAL COMPLICATION 17 0.0009
475 ILEUS 11 0.0009
476 PAIN 542 0.0009
477 BODY TEMPERATURE INCREASED 18 0.0009
478 IMPAIRED GASTRIC EMPTYING 12 0.0009
479 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
480 RETINAL DETACHMENT 8 0.0009
481 ALANINE AMINOTRANSFERASE INCREASED 53 0.0009
482 ERYTHEMA MULTIFORME 8 0.0009
483 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
484 INFLAMMATION 44 0.0009
485 INCONTINENCE 9 0.0009
486 ESCHERICHIA INFECTION 7 0.0009
487 DIVERTICULUM 6 0.0008
488 SEPSIS 94 0.0008
489 PNEUMONIA ASPIRATION 21 0.0008
490 CHOLECYSTITIS 10 0.0008
491 PARALYSIS 12 0.0008
492 DYSKINESIA 34 0.0008
493 PULMONARY CONGESTION 11 0.0008
494 OEDEMA 45 0.0008
495 LEUKOCYTOSIS 15 0.0008
496 HEMIPARESIS 14 0.0008
497 SCAR 14 0.0008
498 ABSCESS 13 0.0008
499 VENTRICULAR FIBRILLATION 9 0.0008
500 GENERALISED OEDEMA 10 0.0008
501 GINGIVAL BLEEDING 11 0.0008
502 MALNUTRITION 9 0.0008
503 DISEASE RECURRENCE 38 0.0008
504 DIZZINESS 398 0.0008
505 RESPIRATORY FAILURE 58 0.0008
506 IMMUNOSUPPRESSION 7 0.0008
507 PRODUCT COMMUNICATION ISSUE 7 0.0008
508 LYMPHOCYTE COUNT DECREASED 14 0.0008
509 HEPATOCELLULAR CARCINOMA 6 0.0008
510 DYSSTASIA 23 0.0008
511 SLEEP APNOEA SYNDROME 15 0.0008
512 PRESYNCOPE 19 0.0008
513 LOSS OF CONSCIOUSNESS 100 0.0008
514 HIATUS HERNIA 10 0.0008
515 HAEMATOMA 20 0.0008
516 HYPOALBUMINAEMIA 6 0.0008
517 DEVICE EXPULSION 50 0.0008
518 FACE OEDEMA 13 0.0008
519 SPLENOMEGALY 9 0.0008
520 HYPOXIA 27 0.0008
521 LIVER DISORDER 34 0.0008
522 INCREASED TENDENCY TO BRUISE 7 0.0008
523 DYSURIA 28 0.0008
524 FEELING COLD 21 0.0008
525 ASCITES 22 0.0007
526 QUALITY OF LIFE DECREASED 10 0.0007
527 DEVICE USE ISSUE 13 0.0007
528 HYPERKALAEMIA 26 0.0007
529 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
530 SPINAL DISORDER 7 0.0007
531 BLOOD POTASSIUM INCREASED 12 0.0007
532 LIVER INJURY 18 0.0007
533 MUSCLE SPASTICITY 9 0.0007
534 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
535 BRONCHITIS 54 0.0007
536 APHASIA 22 0.0007
537 DEVICE DIFFICULT TO USE 48 0.0007
538 ARTHRITIS 57 0.0007
539 DYSTONIA 14 0.0007
540 PULMONARY HYPERTENSION 15 0.0007
541 GLOSSODYNIA 16 0.0007
542 MITRAL VALVE INCOMPETENCE 8 0.0007
543 SINUS TACHYCARDIA 10 0.0007
544 MYOCARDITIS 8 0.0007
545 SWELLING 65 0.0007
546 CARDIAC MURMUR 6 0.0007
547 ELECTROLYTE IMBALANCE 8 0.0007
548 THROMBOSIS 55 0.0007
549 MELAENA 15 0.0007
550 COLD SWEAT 12 0.0007
551 WOUND 19 0.0007
552 DRUG ERUPTION 12 0.0007
553 STEVENS-JOHNSON SYNDROME 15 0.0007
554 CELLULITIS 34 0.0007
555 ATAXIA 8 0.0007
556 JOINT RANGE OF MOTION DECREASED 9 0.0007
557 HEAVY MENSTRUAL BLEEDING 6 0.0007
558 OEDEMA PERIPHERAL 81 0.0007
559 PANCYTOPENIA 37 0.0007
560 TACHYPNOEA 9 0.0007
561 SUDDEN DEATH 7 0.0007
562 PRODUCT USE ISSUE 124 0.0007
563 SKIN ULCER 17 0.0007
564 CEREBRAL INFARCTION 16 0.0007
565 TYPE 2 DIABETES MELLITUS 22 0.0007
566 HYPOTENSION 130 0.0006
567 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
568 TREMOR 107 0.0006
569 HERPES ZOSTER 37 0.0006
570 THERAPEUTIC RESPONSE DECREASED 39 0.0006
571 ASPIRATION 7 0.0006
572 MUSCULOSKELETAL DISCOMFORT 11 0.0006
573 PLATELET COUNT DECREASED 68 0.0006
574 HYPOCALCAEMIA 12 0.0006
575 LUNG DISORDER 31 0.0006
576 BLOOD PRESSURE DECREASED 42 0.0006
577 OSTEOPOROSIS 26 0.0006
578 HEAD INJURY 20 0.0006
579 ORTHOSTATIC HYPOTENSION 11 0.0006
580 BLOOD BILIRUBIN INCREASED 17 0.0006
581 RASH ERYTHEMATOUS 30 0.0006
582 NEPHROPATHY TOXIC 7 0.0006
583 HYPERTENSION 132 0.0006
584 BLOOD CALCIUM DECREASED 7 0.0006
585 MUSCLE TIGHTNESS 10 0.0006
586 BACK DISORDER 10 0.0006
587 DIVERTICULITIS 17 0.0006
588 RENAL FAILURE ACUTE 26 0.0006
589 INTERNAL HAEMORRHAGE 7 0.0006
590 MENTAL STATUS CHANGES 17 0.0006
591 CARDIAC FAILURE 49 0.0006
592 IMPAIRED HEALING 20 0.0006
593 NECK PAIN 34 0.0006
594 OSTEONECROSIS OF JAW 15 0.0006
595 UNINTENTIONAL MEDICAL DEVICE REMOVAL 7 0.0006
596 PULMONARY MASS 9 0.0006
597 BONE DISORDER 11 0.0006
598 BRADYCARDIA 32 0.0006
599 PULMONARY OEDEMA 27 0.0006
600 EYELID OEDEMA 7 0.0006
601 RASH MACULAR 21 0.0006
602 FAECES DISCOLOURED 13 0.0006
603 HAEMATOCHEZIA 33 0.0006
604 ECONOMIC PROBLEM 9 0.0006
605 CHRONIC KIDNEY DISEASE 45 0.0006
606 DEVICE BREAKAGE 24 0.0006
607 PULMONARY EMBOLISM 56 0.0006
608 HEART RATE INCREASED 58 0.0006
609 DEVICE RELATED INFECTION 9 0.0006
610 MOBILITY DECREASED 42 0.0006
611 BLOOD SODIUM DECREASED 11 0.0006
612 CORONARY ARTERY OCCLUSION 8 0.0006
613 ORAL PAIN 13 0.0006
614 RESPIRATORY ARREST 16 0.0006
615 DIPLOPIA 15 0.0006
616 LIP SWELLING 19 0.0006
617 METASTASES TO LIVER 10 0.0006
618 FULL BLOOD COUNT ABNORMAL 6 0.0006
619 NAUSEA 448 0.0006
620 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
621 CYST 7 0.0006
622 HAEMORRHOIDS 11 0.0006
623 HEREDITARY ANGIOEDEMA 6 0.0006
624 ANGINA PECTORIS 16 0.0006
625 ARTHROPATHY 31 0.0006
626 JAUNDICE 15 0.0006
627 PAIN OF SKIN 15 0.0006
628 DECREASED ACTIVITY 6 0.0006
629 LACTIC ACIDOSIS 18 0.0006
630 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
631 GASTRIC DISORDER 19 0.0006
632 CONTUSION 53 0.0005
633 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
634 DRUG INTERACTION 87 0.0005
635 METASTASES TO BONE 9 0.0005
636 END STAGE RENAL DISEASE 10 0.0005
637 OSTEONECROSIS 18 0.0005
638 MUSCULOSKELETAL STIFFNESS 48 0.0005
639 CYTOMEGALOVIRUS INFECTION 9 0.0005
640 FUNGAL INFECTION 18 0.0005
641 NEUTROPHIL COUNT DECREASED 22 0.0005
642 PAIN IN EXTREMITY 159 0.0005
643 SWELLING FACE 35 0.0005
644 INTESTINAL PERFORATION 6 0.0005
645 SPEECH DISORDER 28 0.0005
646 PNEUMONIA 173 0.0005
647 CYSTITIS 17 0.0005
648 URINARY TRACT INFECTION 91 0.0005
649 ASTHENIA 200 0.0005
650 INCORRECT ROUTE OF DRUG ADMINISTRATION 19 0.0005
651 ANKYLOSING SPONDYLITIS 7 0.0005
652 HEPATIC FAILURE 16 0.0005
653 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
654 IMPAIRED DRIVING ABILITY 6 0.0005
655 MALAISE 231 0.0005
656 CONDITION AGGRAVATED 160 0.0005
657 MICTURITION URGENCY 6 0.0005
658 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
659 INSURANCE ISSUE 8 0.0005
660 MUSCLE TWITCHING 12 0.0005
661 PHARYNGEAL OEDEMA 8 0.0005
662 LYMPHOMA 8 0.0005
663 DEHYDRATION 69 0.0005
664 ANKLE FRACTURE 8 0.0005
665 LIMB INJURY 14 0.0005
666 EJECTION FRACTION DECREASED 8 0.0005
667 RENAL IMPAIRMENT 43 0.0005
668 DEEP VEIN THROMBOSIS 33 0.0005
669 RESPIRATORY DISTRESS 14 0.0005
670 BACTERAEMIA 6 0.0005
671 PNEUMOTHORAX 8 0.0005
672 GALLBLADDER DISORDER 9 0.0005
673 UNRESPONSIVE TO STIMULI 13 0.0005
674 CEREBRAL HAEMORRHAGE 18 0.0005
675 OBESITY 8 0.0005
676 RESPIRATORY DISORDER 15 0.0005
677 BURSITIS 6 0.0005
678 DELIRIUM 17 0.0005
679 CONVULSION 28 0.0005
680 PANCREATITIS ACUTE 11 0.0005
681 CHOLELITHIASIS 16 0.0005
682 MEDICATION ERROR 27 0.0005
683 ABASIA 12 0.0005
684 FEMUR FRACTURE 15 0.0005
685 MYELODYSPLASTIC SYNDROME 7 0.0005
686 GASTROENTERITIS 7 0.0005
687 SKIN DISCOLOURATION 22 0.0005
688 PERICARDIAL EFFUSION 11 0.0005
689 ANGIOEDEMA 21 0.0005
690 DYSPHAGIA 45 0.0005
691 BLOOD URINE PRESENT 9 0.0005
692 CARDIOMYOPATHY 7 0.0005
693 HALLUCINATION, VISUAL 10 0.0005
694 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
695 INFUSION RELATED REACTION 31 0.0005
696 CHEST PAIN 86 0.0005
697 WHITE BLOOD CELL COUNT DECREASED 50 0.0005
698 LEUKOPENIA 23 0.0005
699 BLOOD CREATININE INCREASED 30 0.0005
700 DRUG DISPENSING ERROR 7 0.0005
701 EPILEPSY 14 0.0005
702 HAND DEFORMITY 6 0.0005
703 AMENORRHOEA 8 0.0005
704 ROAD TRAFFIC ACCIDENT 19 0.0005
705 EMOTIONAL DISORDER 14 0.0005
706 ABDOMINAL DISCOMFORT 76 0.0005
707 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
708 FIBROMYALGIA 11 0.0005
709 NEURALGIA 11 0.0005
710 BACK PAIN 105 0.0005
711 LUNG INFECTION 7 0.0005
712 SPINAL FRACTURE 9 0.0004
713 FEAR 12 0.0004
714 ARRHYTHMIA 21 0.0004
715 BONE MARROW FAILURE 9 0.0004
716 GENERAL PHYSICAL HEALTH DETERIORATION 51 0.0004
717 RESTLESS LEGS SYNDROME 8 0.0004
718 URINARY INCONTINENCE 13 0.0004
719 HAEMATURIA 15 0.0004
720 DYSPEPSIA 43 0.0004
721 RHABDOMYOLYSIS 18 0.0004
722 HYPERSENSITIVITY 80 0.0004
723 CARDIO-RESPIRATORY ARREST 18 0.0004
724 HAEMOPTYSIS 12 0.0004
725 HEPATITIS 11 0.0004
726 CORONARY ARTERY DISEASE 13 0.0004
727 THROMBOCYTOPENIA 48 0.0004
728 DISORIENTATION 17 0.0004
729 ANXIETY 122 0.0004
730 HEART RATE DECREASED 15 0.0004
731 PALPITATIONS 50 0.0004
732 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
733 PARAESTHESIA 67 0.0004
734 DRUG ADMINISTRATION ERROR 13 0.0004
735 THROAT IRRITATION 19 0.0004
736 CONSTIPATION 92 0.0004
737 COAGULOPATHY 7 0.0004
738 DIABETES MELLITUS 32 0.0004
739 CARDIOGENIC SHOCK 6 0.0004
740 PULMONARY FIBROSIS 8 0.0004
741 NERVOUS SYSTEM DISORDER 13 0.0004
742 SWOLLEN TONGUE 13 0.0004
743 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
744 PRESCRIBED OVERDOSE 8 0.0004
745 HYPOKINESIA 6 0.0004
746 DEPRESSION 94 0.0004
747 MENTAL IMPAIRMENT 10 0.0004
748 HEPATIC ENZYME INCREASED 28 0.0004
749 MENSTRUATION IRREGULAR 11 0.0004
750 RASH 179 0.0004
751 ARTHRALGIA 169 0.0004
752 PARANOIA 7 0.0004
753 DISABILITY 8 0.0004
754 DIARRHOEA 258 0.0004
755 CHROMATURIA 9 0.0004
756 HYPERHIDROSIS 51 0.0004
757 COLITIS 15 0.0004
758 HAEMATEMESIS 10 0.0004
759 NEPHROLITHIASIS 18 0.0004
760 PRURITUS 150 0.0004
761 RIB FRACTURE 8 0.0004
762 ABDOMINAL PAIN UPPER 80 0.0004
763 BLOOD PRESSURE INCREASED 59 0.0004
764 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
765 RENAL FAILURE 51 0.0004
766 DYSPNOEA 216 0.0004
767 JOINT STIFFNESS 10 0.0004
768 JOINT SWELLING 46 0.0004
769 LIVER FUNCTION TEST ABNORMAL 11 0.0004
770 PRODUCT PRESCRIBING ERROR 9 0.0004
771 CONJUNCTIVITIS 7 0.0004
772 EYE SWELLING 14 0.0004
773 ABDOMINAL DISTENSION 39 0.0004
774 RECTAL HAEMORRHAGE 16 0.0004
775 PHOTOPHOBIA 7 0.0004
776 DYSPNOEA EXERTIONAL 14 0.0004
777 ASTHMA 42 0.0004
778 FATIGUE 289 0.0004
779 HYPOGLYCAEMIA 18 0.0004
780 MALIGNANT NEOPLASM PROGRESSION 38 0.0004
781 GAIT DISTURBANCE 71 0.0004
782 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
783 FLATULENCE 21 0.0004
784 FRACTURE 7 0.0004
785 THROAT TIGHTNESS 10 0.0004
786 PSORIATIC ARTHROPATHY 15 0.0004
787 INSOMNIA 98 0.0004
788 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
789 INCREASED APPETITE 7 0.0004
790 EYE DISORDER 12 0.0004
791 MUSCULOSKELETAL PAIN 19 0.0004
792 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
793 HERNIA 7 0.0004
794 CHEST DISCOMFORT 37 0.0004
795 VISUAL ACUITY REDUCED 12 0.0004
796 EAR PAIN 7 0.0004
797 TOOTH DISORDER 8 0.0004
798 RASH PAPULAR 8 0.0004
799 DEVICE ISSUE 32 0.0004
800 ALOPECIA 70 0.0004
801 THERAPY NON-RESPONDER 16 0.0004
802 GASTRIC CANCER 9 0.0004
803 RESTLESSNESS 13 0.0004
804 FALL 118 0.0004
805 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
806 PSORIASIS 46 0.0004
807 HYPOPHAGIA 9 0.0004
808 MUSCULAR WEAKNESS 40 0.0004
809 TREATMENT FAILURE 29 0.0003
810 HYPOKALAEMIA 16 0.0003
811 GASTROINTESTINAL DISORDER 31 0.0003
812 RESPIRATORY TRACT INFECTION 9 0.0003
813 MENTAL DISORDER 15 0.0003
814 DISCOMFORT 21 0.0003
815 ANHEDONIA 9 0.0003
816 SINUSITIS 35 0.0003
817 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
818 URTICARIA 57 0.0003
819 LYMPHADENOPATHY 12 0.0003
820 SEIZURE 39 0.0003
821 ISCHAEMIC STROKE 6 0.0003
822 DRUG INEFFECTIVE 442 0.0003
823 MULTIPLE SCLEROSIS 16 0.0003
824 HEADACHE 209 0.0003
825 KNEE ARTHROPLASTY 7 0.0003
826 MOUTH ULCERATION 7 0.0003
827 HOT FLUSH 25 0.0003
828 EMOTIONAL DISTRESS 40 0.0003
829 URINARY RETENTION 11 0.0003
830 HYPERGLYCAEMIA 12 0.0003
831 JOINT INJURY 7 0.0003
832 FEELING HOT 20 0.0003
833 NASOPHARYNGITIS 60 0.0003
834 BLOOD GLUCOSE ABNORMAL 6 0.0003
835 COUGH 91 0.0003
836 SURGERY 19 0.0003
837 CARDIAC FAILURE CONGESTIVE 26 0.0003
838 NEUTROPENIA 44 0.0003
839 PANCREATITIS 17 0.0003
840 EXTRA DOSE ADMINISTERED 13 0.0003
841 DRUG-INDUCED LIVER INJURY 10 0.0003
842 INTESTINAL OBSTRUCTION 12 0.0003
843 SOMNOLENCE 64 0.0003
844 NEOPLASM PROGRESSION 11 0.0003
845 INFLUENZA LIKE ILLNESS 26 0.0003
846 MIGRAINE 30 0.0003
847 HYPOTHYROIDISM 10 0.0003
848 ERYTHEMA 64 0.0003
849 WEIGHT DECREASED 86 0.0003
850 ATRIAL FIBRILLATION 30 0.0003
851 DEAFNESS 8 0.0003
852 DECREASED APPETITE 71 0.0003
853 TINNITUS 14 0.0003
854 CRYING 11 0.0003
855 AGITATION 22 0.0003
856 SLEEP DISORDER 21 0.0003
857 FEEDING DISORDER 6 0.0003
858 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
859 DYSPHONIA 17 0.0003
860 NASAL CONGESTION 17 0.0003
861 POLLAKIURIA 12 0.0003
862 INTENTIONAL DRUG MISUSE 6 0.0003
863 INTENTIONAL PRODUCT MISUSE 25 0.0003
864 ENCEPHALOPATHY 7 0.0003
865 MOOD SWINGS 9 0.0003
866 ACUTE KIDNEY INJURY 43 0.0003
867 OROPHARYNGEAL PAIN 26 0.0003
868 EPISTAXIS 21 0.0003
869 HYPERSOMNIA 8 0.0003
870 VERTIGO 17 0.0003
871 CARDIAC DISORDER 26 0.0003
872 BALANCE DISORDER 24 0.0003
873 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
874 ACCIDENTAL OVERDOSE 10 0.0003
875 BONE PAIN 16 0.0003
876 PSYCHOTIC DISORDER 8 0.0003
877 RASH GENERALISED 7 0.0003
878 RENAL INJURY 8 0.0003
879 ECZEMA 14 0.0003
880 MUCOSAL INFLAMMATION 7 0.0003
881 UNEVALUABLE EVENT 20 0.0003
882 STOMATITIS 16 0.0003
883 EAR INFECTION 7 0.0003
884 WEIGHT INCREASED 58 0.0003
885 SKIN LESION 7 0.0003
886 PRODUCTIVE COUGH 12 0.0003
887 OVERDOSE 54 0.0003
888 DIABETIC KETOACIDOSIS 6 0.0002
889 HYPONATRAEMIA 14 0.0002
890 PANIC ATTACK 9 0.0002
891 PERIPHERAL SWELLING 38 0.0002
892 MYOCARDIAL INFARCTION 43 0.0002
893 COLITIS ULCERATIVE 11 0.0002
894 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
895 NEUROPATHY PERIPHERAL 23 0.0002
896 DISTURBANCE IN ATTENTION 13 0.0002
897 VIRAL INFECTION 8 0.0002
898 FEELING ABNORMAL 57 0.0002
899 CATARACT 14 0.0002
900 DRY MOUTH 19 0.0002
901 VISUAL IMPAIRMENT 29 0.0002
902 MEMORY IMPAIRMENT 32 0.0002
903 BLOOD POTASSIUM DECREASED 7 0.0002
904 DRY SKIN 31 0.0002
905 COMA 11 0.0002
906 AMNESIA 15 0.0002
907 DEVICE USE ERROR 8 0.0002
908 SUICIDAL IDEATION 21 0.0002
909 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
910 FLUSHING 23 0.0002
911 VISION BLURRED 31 0.0002
912 HALLUCINATION 17 0.0002
913 CEREBROVASCULAR ACCIDENT 38 0.0002
914 DRUG EFFECT INCOMPLETE 8 0.0002
915 MOOD ALTERED 6 0.0002
916 DISEASE PROGRESSION 26 0.0002
917 TREATMENT NONCOMPLIANCE 12 0.0002
918 WHEEZING 13 0.0002
919 INCORRECT DOSE ADMINISTERED 50 0.0002
920 HIP FRACTURE 7 0.0002
921 MYALGIA 37 0.0002
922 ABNORMAL DREAMS 6 0.0002
923 FLUID RETENTION 11 0.0002
924 INFLUENZA 24 0.0002
925 DYSARTHRIA 8 0.0002
926 OCULAR HYPERAEMIA 10 0.0002
927 CONFUSIONAL STATE 34 0.0002
928 LETHARGY 12 0.0002
929 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
930 DRUG EFFECT DECREASED 11 0.0002
931 RHINORRHOEA 13 0.0002
932 ILL-DEFINED DISORDER 12 0.0002
933 LUNG NEOPLASM MALIGNANT 8 0.0002
934 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
936 LIMB DISCOMFORT 6 0.0002
937 RENAL DISORDER 9 0.0002
938 COGNITIVE DISORDER 9 0.0002
939 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
940 NERVOUSNESS 10 0.0002
941 EYE IRRITATION 11 0.0002
942 RASH PRURITIC 10 0.0002
943 IRRITABILITY 11 0.0002
944 DRY EYE 9 0.0002
945 GAIT INABILITY 6 0.0002
946 ANGER 6 0.0002
947 BLOOD GLUCOSE DECREASED 8 0.0002
948 MYELOSUPPRESSION 6 0.0002
949 FEBRILE NEUTROPENIA 11 0.0002
950 ILLNESS 17 0.0002
951 HYPOACUSIS 7 0.0002
952 TOXICITY TO VARIOUS AGENTS 27 0.0002
953 AGGRESSION 8 0.0002
954 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
955 COMPLETED SUICIDE 13 0.0002
956 PRODUCT QUALITY ISSUE 21 0.0002
957 DEPRESSED MOOD 8 0.0002
958 INJECTION SITE BRUISING 12 0.0002
959 NEOPLASM MALIGNANT 10 0.0001
960 BURNING SENSATION 10 0.0001
961 BLISTER 8 0.0001
962 EYE PAIN 8 0.0001
963 PRODUCT DOSE OMISSION 9 0.0001
964 COVID-19 24 0.0001
965 DRUG WITHDRAWAL SYNDROME 11 0.0001
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
967 DYSGEUSIA 9 0.0001
968 DEATH 104 0.0001
969 PRODUCT DOSE OMISSION ISSUE 35 0.0001
970 INJECTION SITE SWELLING 9 0.0001
971 BLOOD GLUCOSE INCREASED 22 0.0001
972 DRUG DOSE OMISSION 19 0.0001
973 DERMATITIS ATOPIC 6 0.0001
974 UNDERDOSE 8 0.0001
975 INJECTION SITE PRURITUS 7 0.0001
976 HOSPITALISATION 16 0.0001
977 ADVERSE DRUG REACTION 9 0.0001
978 BREAST CANCER 9 0.0001
979 NO ADVERSE EVENT 17 0.0001
980 INTENTIONAL OVERDOSE 6 0.0001
981 ACNE 7 0.0001
982 INJECTION SITE PAIN 28 0.0001
983 INJECTION SITE HAEMORRHAGE 7 0.0001
984 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
985 INJECTION SITE REACTION 6 0.0001
986 INJECTION SITE ERYTHEMA 10 0.0001
987 ADVERSE EVENT 7 0.0001
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
989 DRUG DEPENDENCE 11 0.0001